Cargando…

The complete European guidelines on phenylketonuria: diagnosis and treatment

Phenylketonuria (PKU) is an autosomal recessive inborn error of phenylalanine metabolism caused by deficiency in the enzyme phenylalanine hydroxylase that converts phenylalanine into tyrosine. If left untreated, PKU results in increased phenylalanine concentrations in blood and brain, which cause se...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Wegberg, A. M. J., MacDonald, A., Ahring, K., Bélanger-Quintana, A., Blau, N., Bosch, A. M., Burlina, A., Campistol, J., Feillet, F., Giżewska, M., Huijbregts, S. C., Kearney, S., Leuzzi, V., Maillot, F., Muntau, A. C., van Rijn, M., Trefz, F., Walter, J. H., van Spronsen, F. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639803/ https://www.ncbi.nlm.nih.gov/pubmed/29025426 http://dx.doi.org/10.1186/s13023-017-0685-2

Ejemplares similares

Correction to: PKU dietary handbook to accompany PKU guidelines
por: MacDonald, A., et al.
Publicado: (2020)

PKU dietary handbook to accompany PKU guidelines
por: MacDonald, A., et al.
Publicado: (2020)

Diagnostic and management practices for phenylketonuria in 19 countries of the South and Eastern European Region: survey results
por: Giżewska, Maria, et al.
Publicado: (2015)

Bone mineral density is within normal range in most adult phenylketonuria patients
por: Lubout, Charlotte M. A., et al.
Publicado: (2020)

Dietary Liberalization in Tetrahydrobiopterin-Treated PKU Patients: Does It Improve Outcomes?
por: Evers, Roeland A. F., et al.
Publicado: (2022)

When should social service referral be considered in phenylketonuria?
por: van Rijn, Margreet, et al.
Publicado: (2015)

Is the Phenylalanine-Restricted Diet a Risk Factor for Overweight or Obesity in Patients with Phenylketonuria (PKU)? A Systematic Review and Meta-Analysis
por: Rodrigues, Catarina, et al.
Publicado: (2021)

Patient’s thoughts and expectations about centres of expertise for PKU
por: van Wegberg, A. M. J., et al.
Publicado: (2021)

The neonatal tetrahydrobiopterin loading test in phenylketonuria: what is the predictive value?
por: Anjema, Karen, et al.
Publicado: (2016)

Tetrahydrobiopterin responsiveness in phenylketonuria: prediction with the 48-hour loading test and genotype
por: Anjema, Karen, et al.
Publicado: (2013)

Clinical burden of illness in patients with phenylketonuria (PKU) and associated comorbidities - a retrospective study of German health insurance claims data
por: Trefz, K. F., et al.
Publicado: (2019)

Sleep Disturbances in Phenylketonuria: An Explorative Study in Men and Mice
por: Bruinenberg, Vibeke M., et al.
Publicado: (2017)

Long-Term Growth in Phenylketonuria: A Systematic Review and Meta-Analysis
por: Ilgaz, Fatma, et al.
Publicado: (2019)

Parenting a child with phenylketonuria or galactosemia: implications for health-related quality of life
por: ten Hoedt, Amber E., et al.
Publicado: (2011)

The Behavioral Consequence of Phenylketonuria in Mice Depends on the Genetic Background
por: Bruinenberg, Vibeke M., et al.
Publicado: (2016)

Early feeding practices in infants with phenylketonuria across Europe
por: Pinto, A., et al.
Publicado: (2018)

Weaning practices in phenylketonuria vary between health professionals in Europe
por: Pinto, A., et al.
Publicado: (2018)

Social-cognitive functioning and social skills in patients with early treated phenylketonuria: a PKU-COBESO study
por: Jahja, Rianne, et al.
Publicado: (2016)

Long-Term Follow-Up of Cognition and Mental Health in Adult Phenylketonuria: A PKU-COBESO Study
por: Jahja, Rianne, et al.
Publicado: (2017)

Overweight and obesity in PKU: The results from 8 centres in Europe and Turkey
por: Gokmen Ozel, H., et al.
Publicado: (2014)

Special low protein foods for phenylketonuria: availability in Europe and an examination of their nutritional profile
por: Pena, Maria João, et al.
Publicado: (2015)

Living with phenylketonuria in adulthood: The PKU ATTITUDE study
por: Cazzorla, Chiara, et al.
Publicado: (2018)

Biomarkers of Micronutrients in Regular Follow-Up for Tyrosinemia Type 1 and Phenylketonuria Patients
por: van Vliet, Kimber, et al.
Publicado: (2019)

Italian national consensus statement on management and pharmacological treatment of phenylketonuria
por: Burlina, Alberto, et al.
Publicado: (2021)

Can untreated PKU patients escape from intellectual disability? A systematic review
por: van Vliet, Danique, et al.
Publicado: (2018)

Untreated PKU Patients without Intellectual Disability: What Do They Teach Us?
por: van Vliet, Danique, et al.
Publicado: (2019)

Development and psychometric validation of measures to assess the impact of phenylketonuria and its dietary treatment on patients’ and parents’ quality of life: the phenylketonuria – quality of life (PKU-QOL) questionnaires
por: Regnault, Antoine, et al.
Publicado: (2015)

Gut-Microbiome Composition in Response to Phenylketonuria Depends on Dietary Phenylalanine in BTBR Pah(enu2) Mice
por: van der Goot, Els, et al.
Publicado: (2022)

Long-term dietary intervention with low Phe and/or a specific nutrient combination improve certain aspects of brain functioning in phenylketonuria (PKU)
por: Bruinenberg, Vibeke M., et al.
Publicado: (2019)

Optimising amino acid absorption: essential to improve nitrogen balance and metabolic control in phenylketonuria
por: MacDonald, Anita, et al.
Publicado: (2018)

Expert Consensus on the Long-Term Effectiveness of Medical Nutrition Therapy and Its Impact on the Outcomes of Adults with Phenylketonuria
por: Rocha, Júlio César, et al.
Publicado: (2023)

Long-term efficacy and safety of sapropterin in patients who initiated sapropterin at < 4 years of age with phenylketonuria: results of the 3-year extension of the SPARK open-label, multicentre, randomised phase IIIb trial
por: Muntau, Ania C., et al.
Publicado: (2021)

Health economic burden of patients with phenylketonuria (PKU) – A retrospective study of German health insurance claims data
por: Trefz, Friedrich, et al.
Publicado: (2021)

A Specific Nutrient Combination Attenuates the Reduced Expression of PSD-95 in the Proximal Dendrites of Hippocampal Cell Body Layers in a Mouse Model of Phenylketonuria
por: Bruinenberg, Vibeke M., et al.
Publicado: (2016)

Large Neutral Amino Acid Supplementation Exerts Its Effect through Three Synergistic Mechanisms: Proof of Principle in Phenylketonuria Mice
por: van Vliet, Danique, et al.
Publicado: (2015)

Phenylketonuria: reduced tyrosine brain influx relates to reduced cerebral protein synthesis
por: de Groot, Martijn J, et al.
Publicado: (2013)

"MY PKU": increasing self-management in patients with phenylketonuria. A randomized controlled trial
por: ten Hoedt, Amber E, et al.
Publicado: (2011)

Monitoring phenylalanine concentrations in the follow‐up of phenylketonuria patients: An inventory of pre‐analytical and analytical variation
por: Coene, Karlien L. M., et al.
Publicado: (2020)

Acute exercise in treated phenylketonuria patients: Physical activity and biochemical response
por: Mazzola, Priscila Nicolao, et al.
Publicado: (2015)

Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countries
por: Bosch, Annet M, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_r9v8ep89a8svbpq7a7lm2e2kvm